Nu Skin Stock Buy Hold or Sell Recommendation

NUS
 Stock
  

USD 44.72  1.42  3.28%   

Considering the 90-day investment horizon and your slightly conservative level of risk, our recommendation regarding Nu Skin Enterprises is 'Strong Hold'. Macroaxis provides Nu Skin buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Nu Skin positions. The advice algorithm takes into account all of Nu Skin's available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Nu Skin's buy-and-hold perspective. Additionally, see Nu Skin Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Nu Skin and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Nu Skin Enterprises.

Execute Nu Skin Buy or Sell Advice

The Nu Skin recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nu Skin Enterprises. Macroaxis does not own or have any residual interests in Nu Skin Enterprises or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nu Skin's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Nu SkinBuy Nu Skin
Strong Hold

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds of Distress

LowDetails

Economic Sensitivity

Almost mirrors the marketDetails

Analyst Consensus

HoldDetails

Financial Strenth (F Score)

StrongDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Nu Skin Enterprises has a Risk Adjusted Performance of (0.045001), Jensen Alpha of 0.099, Total Risk Alpha of 0.2361 and Treynor Ratio of (0.09)
Nu Skin Enterprises trade advice module can be used to check and cross-verify current advice provided by analysts analyzing the firm's potential to grow using all of fundamental, technical, data market data available now. To make sure Nu Skin Enterprises is not overpriced, please verify all Nu Skin Enterprises fundamentals, including its shares owned by institutions, debt to equity, working capital, as well as the relationship between the gross profit and price to earnings to growth . Given that Nu Skin Enterprises has a price to earning of 10.08 X, we recommend you to check Nu Skin market performance and probability of bankruptcy to ensure the company can sustain itself next year given your latest risk tolerance and investing horizon.

Nu Skin Trading Alerts and Improvement Suggestions

Nu Skin Enterprises generated a negative expected return over the last 90 days
Nu Skin Enterprises has a strong financial position based on the latest SEC filings
Over 98.0% of the company shares are owned by institutional investors
Latest headline from indiandefencenews.info: Consumer Skin Care Devices Market Current Scenario Future Prospects Procter Gamble, Philips, Panasonic, Spectrum Brands, Nu Skin Enterprises Indian Defence News - Indian Defence News

Nu Skin current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nu Skin analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nu Skin analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price53.60
Target Median Price53.00
Target High Price65.00
Recommendation Mean2.40
Number Of Analyst Opinions5
Target Low Price45.00
Average Consensus Hold
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Nu Skin Returns Distribution Density

The distribution of Nu Skin's historical returns is an attempt to chart the future uncertainty of Nu Skin's future price movements. The chart of the probability distribution of Nu Skin stock daily returns describes the distribution of returns around its average expected value. We use Nu Skin Enterprises price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nu Skin returns is essential to provide solid investment advice for Nu Skin stock.
Mean Return-0.09Value At Risk-3.94
Potential Upside3.28Standard Deviation2.45
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nu Skin historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Nu Skin Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nu Skin is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nu Skin Enterprises backward and forwards among themselves. Nu Skin's institutional investor refers to the entity that pools money to purchase Nu Skin's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
State Street CorpCommon Shares6.5 M312.2 M
Vanguard Group IncCommon SharesM287.3 M
Blackrock IncCommon Shares5.8 M277.3 M
Wellington Management Group LlpCommon Shares3.7 M177.2 M
Renaissance Technologies LlcCommon Shares2.7 M127.9 M
Dimensional Fund Advisors LpCommon Shares1.7 M81.9 M
Capital World InvestorsCommon Shares1.1 M52.7 M
Note, although Nu Skin's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nu Skin Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(60.16 M)(70.37 M)(66.07 M)(63.82 M)(73.4 M)(79.19 M)
Depreciation Amortization and Accretion71.56 M83 M121.11 M120.15 M138.18 M110.9 M
Net Cash Flow or Change in Cash and Cash Equivalents69.15 M(39.49 M)(51.28 M)67.05 M60.35 M65.11 M
Net Cash Flow Business Acquisitions and Disposals(31.75 M)(38.51 M)(8.07 M)(14.95 M)(13.45 M)(14.52 M)
Issuance Purchase of Equity Shares(47.29 M)(58.79 M)(3.15 M)(138.57 M)(159.36 M)(171.94 M)
Issuance Repayment of Debt Securities(36.23 M)22.66 M(69.45 M)(28.21 M)(25.39 M)(26.06 M)
Payment of Dividends and Other Cash Distributions(76.06 M)(80.58 M)(82.19 M)(78.39 M)(70.55 M)(76.12 M)
Net Cash Flow from Financing(159.57 M)(116.71 M)(154.79 M)(245.17 M)(104.7 M)(112.97 M)
Net Cash Flow from Investing(91.96 M)(108.76 M)(71.41 M)(79.43 M)(88.73 M)(95.73 M)
Net Cash Flow Investment Acquisitions and Disposals(63 K)116 K2.73 M(656 K)(754.4 K)(813.96 K)
Net Cash Flow from Operations302.56 M202.74 M177.93 M379.14 M141.58 M219.17 M
Effect of Exchange Rate Changes on Cash18.13 M(16.75 M)(3.01 M)12.51 M14.38 M15.52 M
Share Based Compensation19.31 M26.61 M9.91 M24.06 M27.67 M24.77 M

Nu Skin Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nu Skin or Consumer Defensive sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nu Skin stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nu Skin stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.1
β
Beta against DOW1.01
σ
Overall volatility
2.50
Ir
Information ratio 0.0394

Nu Skin Volatility Alert

Nu Skin Enterprises exhibits very low volatility with skewness of -0.8 and kurtosis of 1.24. However, we advise investors to further study Nu Skin Enterprises technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nu Skin's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nu Skin's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Nu Skin Implied Volatility

Nu Skin's implied volatility exposes the market's sentiment of Nu Skin Enterprises stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nu Skin's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nu Skin stock will not fluctuate a lot when Nu Skin's options are near their expiration.

Nu Skin Fundamentals Vs Peers

Comparing Nu Skin's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nu Skin's direct or indirect competition across all of the common fundamentals between Nu Skin and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nu Skin or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nu Skin's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nu Skin by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Nu Skin to competition
FundamentalsNu SkinPeer Average
Return On Equity16.30 %(0.31) %
Return On Asset9.46 %(0.14) %
Profit Margin5.46 %(1.27) %
Operating Margin13.68 %(5.51) %
Current Valuation2.27 B16.62 B
Shares Outstanding49.82 M571.82 M
Shares Owned by Insiders1.47 %10.09 %
Shares Owned by Institutions98.31 %39.21 %
Number of Shares Shorted4.11 M4.71 M
Price to Earning10.08 X28.72 X
Price to Book2.39 X9.51 X
Price to Sales0.83 X11.42 X
Revenue2.7 B9.43 B
Gross Profit2.03 B27.38 B
EBITDA368.78 M3.9 B
Net Income147.27 M570.98 M
Cash and Equivalents355.97 M2.7 B
Cash per Share7.14 X5.01 X
Total Debt503.78 M5.32 B
Debt to Equity0.55 %48.70 %
Current Ratio1.65 X2.16 X
Book Value Per Share18.69 X1.93 K
Cash Flow from Operations141.58 M971.22 M
Short Ratio5.67 X4.00 X
Earnings Per Share4.44 X3.12 X
Price to Earnings To Growth1.67 X4.89 X
Number of Employees4.6 K18.84 K
Beta1.25-0.15
Market Capitalization2.23 B19.03 B
Total Asset1.51 B29.47 B
Retained Earnings1.65 B9.33 B
Working Capital298.8 M1.48 B
Current Asset706.39 M9.34 B
   Sale by Steven Lund of 2175 shares of Nu Skin [view details]

About Nu Skin Buy or Sell Advice

When is the right time to buy or sell Nu Skin Enterprises? Buying financial instruments such as Nu Skin Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Nu Skin investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Receivables50.38 M63.37 M41.3 M39.52 M
Inventories275.89 M314.37 M399.93 M319.1 M

Use Investing Ideas to Build Portfolios

In addition to having Nu Skin in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Realty Thematic Idea Now

Realty
Realty Theme
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty theme has 40 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Theme or any other thematic opportunities.
View All  Next Launch Realty
Additionally, see Nu Skin Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Nu Skin Enterprises information on this page should be used as a complementary analysis to other Nu Skin's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Nu Skin Stock analysis

When running Nu Skin Enterprises price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know Nu Skin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.16
Market Capitalization
2.2 B
Quarterly Revenue Growth YOY
-0.11
Return On Assets
0.0916
Return On Equity
0.15
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of Nu Skin that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine Nu Skin value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.